Cargando…
Tumour mutation status and melanoma recurrence following a negative sentinel lymph node biopsy
BACKGROUND: A proportion of patients develop recurrence following a tumour-negative sentinel lymph node biopsy (SLNB). This study aimed to explore whether melanoma patients with BRAF or NRAS mutant tumours have an increased risk of developing disease recurrence following a negative SLNB compared to...
Autores principales: | Adler, Nikki R., Wolfe, Rory, McArthur, Grant A., Kelly, John W., Haydon, Andrew, McLean, Catriona A., Mar, Victoria J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959932/ https://www.ncbi.nlm.nih.gov/pubmed/29755118 http://dx.doi.org/10.1038/s41416-018-0088-8 |
Ejemplares similares
-
Tumour mutation status and sites of metastasis in patients with cutaneous melanoma
por: Adler, Nikki R, et al.
Publicado: (2017) -
Cutaneous Melanoma and Sentinel Lymph Node Biopsy
por: van Akkooi, A. C. J., et al.
Publicado: (2008) -
Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma
por: Falk Delgado, Alberto, et al.
Publicado: (2019) -
Prospective study of sentinel lymph node biopsy for conjunctival melanoma
por: Cohen, Victoria M L, et al.
Publicado: (2013) -
Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma
por: El Sharouni, Mary-Ann, et al.
Publicado: (2019)